BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhou X, Zhang G, Tian Y, Seno M. p53 Status Correlates with the Risk of Recurrence in Non-Muscle Invasive Bladder Cancers Treated with Bacillus Calmette–Guérin: A Meta-Analysis. PLoS ONE 2015;10:e0119476. [DOI: 10.1371/journal.pone.0119476] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Li Y, Zhang K, Yang F, Jiao D, Li M, Zhao X, Xu C, Liu S, Li H, Shi S, Yang B, Yang L, Han D, Wen W, Qin W. Prognostic Value of Vascular-Expressed PSMA and CD248 in Urothelial Carcinoma of the Bladder. Front Oncol 2021;11:771036. [PMID: 34869004 DOI: 10.3389/fonc.2021.771036] [Reference Citation Analysis]
2 Shao Y, Hu X, Yang Z, Lia T, Yang W, Wu K, Ren S, Xiong S, Dou W, Feng S, Wang Y, Liu Y, Wu K, Li X. Prognostic factors of non-muscle invasive bladder cancer: a study based on next-generation sequencing. Cancer Cell Int 2021;21:23. [PMID: 33407469 DOI: 10.1186/s12935-020-01731-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Stec R, Cierniak S, Lubas A, Brzóskowska U, Syryło T, Zieliński H, Semeniuk-Wojtaś A. Intensity of Nuclear Staining for Ki-67, p53 and Survivin as a New Prognostic Factor in Non-muscle Invasive Bladder Cancer. Pathol Oncol Res 2020;26:1211-9. [PMID: 31346958 DOI: 10.1007/s12253-019-00678-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
4 Soria F, Krabbe LM, Todenhöfer T, Dobruch J, Mitra AP, Inman BA, Gust KM, Lotan Y, Shariat SF. Molecular markers in bladder cancer. World J Urol 2019;37:31-40. [PMID: 30259123 DOI: 10.1007/s00345-018-2503-4] [Cited by in Crossref: 59] [Cited by in F6Publishing: 54] [Article Influence: 11.8] [Reference Citation Analysis]
5 He Y, Wang N, Zhou X, Wang J, Ding Z, Chen X, Deng Y. Prognostic value of ki67 in BCG-treated non-muscle invasive bladder cancer: a meta-analysis and systematic review. BMJ Open 2018;8:e019635. [PMID: 29666128 DOI: 10.1136/bmjopen-2017-019635] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
6 Pietzak EJ, Bagrodia A, Cha EK, Drill EN, Iyer G, Isharwal S, Ostrovnaya I, Baez P, Li Q, Berger MF, Zehir A, Schultz N, Rosenberg JE, Bajorin DF, Dalbagni G, Al-Ahmadie H, Solit DB, Bochner BH. Next-generation Sequencing of Nonmuscle Invasive Bladder Cancer Reveals Potential Biomarkers and Rational Therapeutic Targets. Eur Urol 2017;72:952-9. [PMID: 28583311 DOI: 10.1016/j.eururo.2017.05.032] [Cited by in Crossref: 184] [Cited by in F6Publishing: 200] [Article Influence: 30.7] [Reference Citation Analysis]
7 El-gendi S, Abu-sheasha G. Ki-67 and Cell Cycle Regulators p53, p63 and cyclinD1 as Prognostic Markers for Recurrence/ Progression of Bladder Urothelial Carcinoma. Pathol Oncol Res 2018;24:309-22. [DOI: 10.1007/s12253-017-0250-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
8 Wu Y, Li Y, Zhao X, Dong D, Tang C, Li E, Geng Q. Combined detection of the expression of Nm23-H1 and p53 is correlated with survival rates of patients with stage II and III colorectal cancer. Oncol Lett 2017;13:129-36. [PMID: 28123532 DOI: 10.3892/ol.2016.5425] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
9 Wang L, Yu X, Li J, Zhang Z, Hou J, Li F. Prognostic significance of p53 expression in patients with esophageal cancer: a meta-analysis. BMC Cancer 2016;16:373. [PMID: 27370310 DOI: 10.1186/s12885-016-2427-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
10 Luo Y, Zhang X, Mo M, Tan Z, Huang L, Zhou H, Wang C, Wei F, Qiu X, He R, Chen G. High Ki-67 Immunohistochemical Reactivity Correlates With Poor Prognosis in Bladder Carcinoma: A Comprehensive Meta-Analysis with 13,053 Patients Involved. Medicine (Baltimore) 2016;95:e3337. [PMID: 27082587 DOI: 10.1097/MD.0000000000003337] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
11 Miyata Y, Sakai H. Predictive Markers for the Recurrence of Nonmuscle Invasive Bladder Cancer Treated with Intravesical Therapy. Dis Markers 2015;2015:857416. [PMID: 26681820 DOI: 10.1155/2015/857416] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]